Quidel to Present Virtually at Raymond James Human Health Innovation Conference 2021
Quidel Corporation (NASDAQ: QDEL) will present at the Raymond James Human Health Innovation Conference 2021 virtually on June 21, 2021, at 1:20 p.m. ET. CEO Douglas Bryant and CFO Randy Steward will discuss the company’s business and financial developments in a Q&A format. The presentation will be accessible via live webcast on the company’s Investor Relations webpage, with a replay available for 14 days. Quidel is a leading provider of rapid diagnostic testing solutions, known for innovation in the medical device industry, including COVID-19 testing.
- None.
- None.
Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it will present at the Raymond James Human Health Innovation Conference 2021 to be held virtually on Monday, June 21, 2021.
Douglas Bryant, president and chief executive officer, and Randy Steward, chief financial officer, will present on that day at 1:20 p.m. Eastern time (10:20 a.m. Pacific time) in a question-and-answer teleconference format. During the presentation, the company will discuss business and financial developments and trends. The company's statements may contain or constitute material information that has not been previously disclosed.
A live webcast and audio archive of the presentation will be available via the Investor Relations section of the company’s website at http://ir.quidel.com or by clicking the link below:
https://kvgo.com/rj-health/quidel-corporation-june-2021.
Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the company’s website for 14 days.
About Quidel Corporation
Quidel Corporation (Nasdaq: QDEL) is a leading manufacturer of diagnostic solutions at the point of care, delivering a continuum of rapid testing technologies that further improve the quality of health care throughout the globe. An innovator for over 40 years in the medical device industry, Quidel pioneered the first FDA-cleared point-of-care test for influenza in 1999 and was the first to market a rapid SARS-CoV-2 antigen test in the U.S. Under trusted brand names Sofia®, Solana®, Lyra®, Triage® and QuickVue®, Quidel’s comprehensive product portfolio includes tests for a wide range of infectious diseases, cardiac and autoimmune biomarkers, as well as a host of products to detect COVID-19. With products made in America, Quidel’s mission is to provide patients with immediate and frequent access to highly accurate, affordable testing for the good of our families, our communities and the world. For more information about Quidel, visit quidel.com.
View our story told by our people at www.quidel.com/ourstory.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210610005950/en/
FAQ
When is Quidel Corporation presenting at the Raymond James Human Health Innovation Conference?
Who will represent Quidel Corporation at the conference?
How can I access the Quidel Corporation presentation?
Will there be a replay of the Quidel Corporation conference presentation?
What topics will be discussed during Quidel Corporation's presentation?
